Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Dec 27, 2024

$1.80

P/E Ratio

N/A

Market Cap

$83.84M

Loading...
Description

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Metrics

Overview

  • HQCupertino, CA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerRVPH
  • Price$1.8-3.23%

Trading Information

  • Market cap$83.84M
  • Float85.21%
  • Average Daily Volume (1m)5,602,896
  • Average Daily Volume (3m)2,056,590
  • EPS-$1.11

Company

  • RevenueN/A
  • Rev growth (1yr)N/A
  • Net income-$8.37M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$8.46M
  • EV$43.20M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/BN/A
Documents